Hosoyamada K

References (1)

Title : Metformin dose increase versus added linagliptin in non-alcoholic fatty liver disease and type 2 diabetes: An analysis of the J-LINK study - Komorizono_2021_Diabetes.Obes.Metab_23_832
Author(s) : Komorizono Y , Hosoyamada K , Imamura N , Kajiya S , Hashiguchi Y , Ueyama N , Shinmaki H , Koriyama N , Tsukasa M , Kamada T
Ref : Diabetes Obes Metab , 23 :832 , 2021
Abstract : Komorizono_2021_Diabetes.Obes.Metab_23_832
ESTHER : Komorizono_2021_Diabetes.Obes.Metab_23_832
PubMedSearch : Komorizono_2021_Diabetes.Obes.Metab_23_832
PubMedID: 33236464